ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Valencia, VC, ESP:

Recently updated

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Valencia, Spain and 59 other locations

States, where 2 out of 3 non-traumatic amputations derive from diabetes. This is why the main objective of this project is to establish a st...

Invitation-only
Diabetic Foot
Other: Orthopedic intervention
University of Valencia

Valencia, Spain

Locations recently updated

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 175 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Valencia, Spain and 78 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

València, Spain and 652 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

Phase 2

ITBMed

Valencia, Spain and 37 other locations

We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doi...

Active, not recruiting
Diabetes Mellitus, Type 2
Chronic Kidney Disease
Drug: Placebo (Semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 32 other locations

the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Overweight or Obesity
Drug: Placebo
Drug: Retatrutide

Phase 2

Lilly
Lilly

Valencia, Valenciana, Comunitat, Spain and 38 other locations

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...

Enrolling
Type 2 Diabetes
Chronic Kidney Disease
Drug: Placebo
Drug: Cagrilintide

Phase 2

Novo Nordisk
Novo Nordisk

Valencia, Spain and 118 other locations

Finerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known...

Active, not recruiting
Type 2 Diabetes Mellitus
Chronic Kidney Disease
Drug: Finerenone (BAY94-8862 ) 20 mg
Drug: Finerenone Placebo

Phase 2

Bayer
Bayer

Valencia, Spain and 188 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems